⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

February 4, 2008British Journal of PharmacologyOpen Access

Role of gp130‐mediated signalling pathways in the heart and its impact on potential therapeutic aspects

View Full Paper

Ask AI

Bookmark

Share

Design

Review

Authors

PFPhilipp FischerInnsbruck Medical University DHDenise Hilfiker‐KleinerHeart Failure & Transplant

Discussion

Loading...

Member takes

Implication

Gp130 modulation warrants caution in heart failure; leaves open development of context-specific therapies.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Fischer et al. (2008) studied this question.

synapsesocial.com/papers/6a092f054c1e2db30bd261c4 https://doi.org/10.1038/bjp.2008.1

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders.1996 · 644 citations
2Loss of myocardial LIF receptor in experimental heart failure reduces cardiotrophin-1 cytoprotection. A role for neurohumoral agonists?2007 · 39 citations
3Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy2000 · 276 citations
4STAT3-Dependent Mouse Embryonic Stem Cell Differentiation Into Cardiomyocytes2007 · 72 citations
5Prognostic value of interleukin‐6, plasma viscosity, fibrinogen, von Willebrand factor, tissue factor and vascular endothelial growth factor levels in congestive heart failure2003 · 100 citations